Prevalence and Characterization of the Mechanisms of Macrolide, Lincosamide, and Streptogramin Resistance in Isolates of Streptococcus pneumoniae
- 1 September 1998
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 42 (9), 2425-2426
- https://doi.org/10.1128/aac.42.9.2425
Abstract
Of a total of 147 erythromycin-resistant Streptococcus pneumoniae isolates, 64 (43.5%) were resistant to erythromycin, clindamycin, and streptogramin B (MLS B phenotype), 57 of which possessed the ermB gene. Eighty-two (55.8%) were resistant to erythromycin alone (M phenotype), 81 of which possessed the mefE gene. One was erythromycin and streptogramin B resistant but susceptible to clindamycin (MS phenotype) and possessed neither the erm gene nor the mefE gene.Keywords
This publication has 5 references indexed in Scilit:
- Intrapulmonary steady-state concentrations of clarithromycin and azithromycin in healthy adult volunteersAntimicrobial Agents and Chemotherapy, 1997
- Novel mechanism of macrolide resistance in Streptococcus pneumoniaeDiagnostic Microbiology and Infectious Disease, 1996
- Erythromycin resistance by ribosome modificationAntimicrobial Agents and Chemotherapy, 1995
- Genetic diversity of penicillin-binding protein 2B and 2X genes from Streptococcus pneumoniae in South AfricaAntimicrobial Agents and Chemotherapy, 1993
- Substrate‐and Antibiotic‐Binding Sites at the Peptidyl‐Transferase Centre of Escherichia coli RibosomesEuropean Journal of Biochemistry, 1971